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Background: The main aim was to investigate the effect of using two brief feedback scales in mental health
out-patient treatment six weeks after starting treatment, compared to treatment as usual. Hypotheses were that use
of feedback scales would improve treatment alliance and patient satisfaction.
Methods: An open parallel-group randomised controlled trial was conducted in an out-patient unit in a mental
health hospital in Central Norway. Eight therapists trained in using the feedback scales in the Partners for Change
Outcome Management System (PCOMS) treated the intervention group. Seventeen therapists treated the controls,
providing treatment without using feedback scales. The main outcome measures were treatment alliance and
patient satisfaction.
Results: Seventy-five patients participated. There were no differences between the groups in the intention to treat (ITT)
analyses on alliance (mean difference = 0.08, 95% CI −0.44, 0.59, p = 0.760) or satisfaction (mean difference = 0.24, 95%
CI −1.85, 2.32, p = 0.819), and no statistically significant differences between the groups in the per protocol (PP, n = 58)
analyses on alliance (mean difference = 0.32, 95% CI −0.84, 3.16, p = 0.137) or satisfaction (mean difference = 1.16, 95%
CI −0.84, 3.16, p = 0.248) six weeks after the treatment started. The effect size in favour of the PCOMS group increased
from 0.07 for alliance and 0.06 for satisfaction in the intention to treat analysis to 0.40 on alliance and 0.31 for
satisfaction in the per protocol analysis. Among the other outcomes, the PCOMS group had better motivation for
treatment (estimated mean difference ITT: 0.29, 95% CI 0.00 to 0.57, p = 0.05, PP: 0.28, 95% CI 0.04, 0.52, p = 0.024).
Conclusion: Six weeks after starting treatment, there were no effects on alliance and satisfaction from using two brief
feedback scales. Since the per protocol analyses showed higher effect sizes, future investigations in a larger study with
longer follow-up are warranted.
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User participation is highly valued and encouraged in
the Western world, and there are several proposed bene-
fits from user participation in health care [1-5]. User
participation is commonly described on two levels: on a
system level when users are representatives in boards
and groups, and on an individual level when patients are* Correspondence: marit.b.rise@ntnu.no
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reproduction in any medium, provided the orbeing involved in discussions and decisions regarding
their own treatment. Many have described and defined
user participation [6-13]. These definitions include
patients’ involvement in their own treatment [7,14],
patients’ right to be involved in decision-making [9],
patient’s implementation and management of their own
care [12], and a change of patient role from passive reci-
pients to active participants [15]. These definitions share
one important aspect: the patient’s perspective and influ-
ence on his or her treatment. This is in line with one of
the main arguments for user participation in general,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of the health services
Patients and professionals perceive the quality of health
care differently, since patients focus more on access, re-
sponsiveness, good communication, and information, as
well as appropriate treatment, relief of symptoms, and
improved health [11]. To measure patient satisfaction
through surveys is the most common way to assess
patients’ view on health care services [11,16]. Patient satis-
faction is also one of the most common outcome mea-
sures when interventions intended to enhance individual
patient participation are investigated [17,18]. Although
many have argued that patient satisfaction is insufficiently
defined [11,16,19], satisfaction is widely assessed in several
aspects of health care; in the health system as a whole, in
specific areas of health care i.e. general practice, in specific
health care organisations such as hospital units, for spe-
cific clinicians, and for specific treatment approaches [11].
Regardless of the health care setting, the relationship
between the patient and the provider is one of the most
important factors affecting patient satisfaction [16]. Im-
proving interpersonal issues is therefore highly recom-
mended to enhance patient satisfaction [16]. Caring and
respectful relationships between patient and provider are
vital for patient satisfaction [20]. The relationship be-
tween patient and provider has been strongly empha-
sised in mental health care, and has been described as
encompassing three parts: a working alliance, a transfer-
ence configuration, and a real relationship [21,22]. The
working alliance is considered to be the most fundamen-
tal for effective treatment [21]. Although the term treat-
ment or working alliance originated in psychoanalysis, it
can be generalized to all forms of psychotherapy [23].
Treatment or working alliance is described as the bond
of collaboration and affection between patient and pro-
fessional [24], and as a concept includes three features:
that the patient and provider agree on goals, that they
assign tasks, and that they develop bonds [23]. Research
has repeatedly shown that there is a consistent relation-
ship between a strong treatment alliance and a good
treatment outcome [24].
Many have argued for systematically assessing feedback
from patients during treatment in mental health care [25-
29]. Such feedback consists of how the patients perceive
the treatment outcome and how the patients experience
the treatment session. Systematically assessing feedback
from patients is part of an increased focus on the patient’s
individual progress during treatment [25]. The main ques-
tion is thus not whether a treatment works in general, but
whether this specific treatment works for this specific pa-
tient [25]. The main argument for assessing feedback is
twofold. Firstly, when given knowledge of the patient’s
situation at the beginning of treatment, it is possible to
predict the expected course of change for a successfultreatment process [25]. Monitoring outcomes during
treatment makes it possible to detect any deviations from
the expected course, and this is vital to ensure good treat-
ment outcomes and to prevent drop-out [30]. Secondly,
measurements of the patient’s perception of the outcome
and the consultations in every treatment session can be
used actively to determine whether the current treatment
is appropriate, whether further treatment is needed, and
to alert the therapist when the patient is not progressing
as expected [25,29].
Although these arguments are directed at improving
the outcome from treatment, the process of asking for
and discussing patient feedback during treatment
strongly involve the patient’s perspective and thereby in-
crease the patient’s participation both in the consulta-
tions and in the treatment process as a whole. Others
have previously described interventions where patients’
rating of health status and quality of life are fed back to
the providers as enhancing patient participation [17].
Given that user participation means including the
patient’s perspective [7,13,14], it would be reasonable for
the patient to partake in evaluation and the management
of the treatment process. Since participation in the
decision-making process is emphasised as a vital part of
user participation [7,10,13,31], participation would mean
that the patient is involved in deciding whether the
current treatment should continue or be altered. Ex-
changing information through a dialogue between pa-
tient and therapist has also been emphasised as a core
aspect of user participation [13].
Increasing participation has also been described as a
redistribution of power [32]. Inviting the patient to par-
take in evaluation and decision-making is a concrete
way to involve the patient more, and would transfer
some power over the treatment process from the profes-
sional to the patient. To assess and collect comprehen-
sible feedback data, and to monitor these data during
the treatment process, makes it feasible for the patient
and provider to evaluate and discuss treatment progress
as equal partners. Concretely assessing feedback system-
atically invites the patient to exchange information with
the provider, to evaluate the treatment effect and the
consultation, to discuss potential improvements, and to
determine whether the treatment approach is appropri-
ate or should be altered. Systematically assessing and
monitoring feedback from patients on the treatment
outcome is thus a practical tool of user participation on
the individual level.
Effort has been made to simplify the process of collect-
ing and using patient feedback data, and to make it prac-
tical for both patients and professionals. Feedback
systems have been developed to monitor the treatment
progress from the patients’ point of view, i.e. the Out-
come Questionnaire-45 (OQ-45) [33] and the Partners
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[30]. These systems use standardised feedback scales to
collect the patient’s views on outcomes in every consult-
ation, and the results are discussed by the patient and
the therapist during the treatment process [29]. A meta-
analysis of studies on the effect of the OQ-45 and the
PCOMS showed that patients who experienced little
progress during treatment were detected through sys-
tematically assessing feedback, and they obtained better
treatment outcomes than patients did where feedback
was not assessed [29].
While the OQ-45 includes a rather extensive scale
with 45 items, the Partners for Change Outcome Man-
agement System (PCOMS) includes two short feedback
scales with four items each: the Outcome Rating Scale
(ORS) and the Session Rating Scale (SRS) [30]. The ORS
is used at the beginning of each treatment session to as-
sess the patients’ rating of treatment outcome last week,
or since the last session. The SRS is used at the end of
each session to assess the patients’ rating of the current
session. Only a few randomised controlled trials have
investigated the effect of using the brief feedback scales
in the PCOMS [29]. These trials have investigated effects
in mental health treatment [34], in couples therapy
[35,36], and in training and supervision of psychology
students [37]. All four trials focused on treatment out-
come measured by the ORS and found that using the
PCOMS scales during treatment was superior to treat-
ment as usual.
Aim and hypotheses
To discuss the patient’s perception of the treatment out-
come in some manner is widely acknowledged as an im-
portant and inherent part of all treatment for mental
health problems. Using concrete feedback scales where
the patient is repeatedly asked to evaluate and rate the
treatment and the consultations, is a more definite way
to assess and collect the patient’s views. Scales are a
quantified form of patient feedback which can be used
in further discussions on how to improve the treatment.
Collecting feedback scales could also be considered a
strong and definite signal that the patient’s views matter.
It would therefore be of interest whether routinely using
feedback scales to assess and monitor the patient’s views
increases the alliance and satisfaction in early phases of
treatment. Treatment including the use of feedback
scales should therefore be compared to usual treatment,
where feedback scales are not used. No studies so far
have investigated the short-term effect of using brief
feedback scales, such as the PCOMS, on treatment alli-
ance and patient satisfaction.
The aim was therefore to investigate the short-term
effects on treatment alliance and patient satisfaction
from using the PCOMS scales (ORS and SRS) in out-patient mental health treatment, compared to treatment
without using feedback scales (treatment as usual).
One of the arguments for using feedback scales is that
a strong treatment alliance increases the possibility for a
good treatment outcome [26]. Treatment alliance is con-
sidered to be an important predictor for outcome in
mental health care [30,38,39], and it is found that the
degree of treatment alliance can be established after only
a few consultations [38]. Hypothesis 1 was therefore that
the use of the PCOMS scales (ORS and SRS) would lead
to stronger treatment alliance than treatment as usual,
six weeks after starting treatment. In this study we
defined treatment alliance as the patient’s perception of
a relational bond and good collaboration with the ther-
apist [40].
It has also been argued that using the ORS and SRS
scales to ask patients for feedback during treatment helps
foster a cooperative and accountable relationship between
patient and professional [26]. The relationship between
patient and provider is the most influential factor on pa-
tient satisfaction [41,42], and it would be reasonable to be-
lieve that the use of feedback scales would lead to
improved patient satisfaction. Hypothesis 2 was therefore
that the use of the PCOMS scales (ORS and SRS) would
lead to a higher degree of patient satisfaction than treat-
ment as usual, six weeks after starting treatment.
Secondary outcomes were mental health symptoms,
patient activation, health-related quality of life, patient
motivation, and patient participation.
Methods
This was an open, randomised parallel-group controlled
trial performed according to the principles of the Hel-
sinki Declaration. The Regional Committee for Medical
and Health Research Ethics, Central Norway, and the
hospital’s management approved of the study. Partici-
pants had to sign an informed consent and were
informed that they could withdraw during the study.
Data collection was conducted from February 2010 to
March 2011.
The study was carried out in an out-patient unit in a
mental health hospital in Central Norway (Trondheim).
The hospital, a part of St. Olav’s Hospital Trust, covers a
catchment area of 96,000 people, with urban and semi-
rural areas including parts of a large Norwegian city. The
out-patient unit treats patients with all types of mental
health diagnoses that do not require hospitalisation.
Participants
All patients offered treatment at the out-patient unit be-
tween six weeks and three months after referral were eli-
gible. The lower limit of six weeks was needed to allow
for baseline assessment, randomisation, and treatment
allocation in the units. There were no exclusion criteria.
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were responsible for individual treatment were eligible
for participating in the study.
Recruitment
Invitation to participate was mailed to the patients to-
gether with the treatment approval letter. One week
after the invitation was mailed an employee at the de-
partment or the 1st author (MBR) phoned the patients
asking if they wanted to participate in the study. Those
who accepted were invited to meet with the 1st author.
During this meeting, oral and written information was
given and a written consent was signed. Three patients
wanted to participate without meeting with the re-
searcher. They were informed by phone, received the
written consent by mail, and returned it by mail.
All 29 therapists in the out-patient unit who provided
and were responsible for individual treatment were
invited to participate in the study. The invitation
informed that they must be willing to receive training in
use of the PCOMS scale on two specific days. Ten thera-
pists volunteered to participate in the study, but only 8
could participate in the training at the given times. The
two therapists who weren’t able to participate in the
training sessions and six other therapists were recruited
to participate in treating the treatment as usual group.
The six therapists who had not volunteered were asked
by the unit manager to participate. Due to administrative
turn-over and other unanticipated difficulties in allocat-
ing control patients to therapists during the trial, the
group of treatment as usual therapists had to be
extended to 17 during the study. In total 86% of all
therapists in the out-patient units at the hospital who
provided individual treatment participated in the study.
Intervention
The intervention therapists were trained to administer
the feedback system Partners for Change Outcome Man-
agement System (PCOMS) [30] during the treatment
they usually provide. PCOMS therapists received 12 h of
training during two days, with four weeks apart, with re-
spectively eight and four hours of training. In addition,
the therapists could contact the instructor at their own
will. The training the PCOMS therapists received was
similar to previous studies [34-37], and in accordance
with training given for clinical purposes to improve pa-
tient functioning and progress [43]. Training was given
by an experienced instructor who did not participate in
the research group. The instructor has been trained by
the founders of the PCOMS, and has extensive experi-
ence both from using the system in clinical practice and
from teaching other clinicians. Training included the ra-
tionale for the use of patient feedback and feedback
scales, the practical use of the feedback scales, and howto incorporate the use of data from the scales in the
treatment process.
The use of the PCOMS consisted of administering two
feedback scales in every treatment session, one at the be-
ginning of the session (the Outcome Rating Scale, or
ORS), and one at the end (the Session Rating Scale, or
SRS) [30]. Completing and scoring each scale takes less
than one minute. Both scales consist of four questions
scored on a 10 cm scale. In the ORS the patients rate their
own functioning during the last week, or since the last
treatment session, individually, interpersonally, socially,
and generally. On the SRS, the patients rate the current
session on relations with the therapist and the degree of
agreement on goals, methods, and treatment approach.
Based on the patients’ initial ORS score, a progress
curve was produced with a dotted line representing the
expected trajectory of change for patients with similar
ORS score in the first session [30]. The therapist had been
trained to use this curve together with the patient to
evaluate treatment progress. They had also learned to dis-
cuss the SRS scores with the patients to establish what
was working in the session and what could be improved.
The intervention thus consisted of systematically using
the ORS and SRS scales to assess feedback from the pa-
tient on treatment outcome and the quality of the session.
To ensure fidelity in the PCOMS group, the patient
feedback scales were collected after each consultation and
the numbers of scales were compared to the total number
of consultations registered on each participant in the
clinic’s administrative data system. The controls received
treatment as usual. To fortify fidelity in the treatment as
usual group the therapists were repeatedly instructed to
avoid using any feedback scales during treatment.
Both PCOMS and treatment as usual therapists were
free to choose treatment approaches for their patients,
and no recommendations or limitations were made, due
to the study. The therapists thus chose the treatment ap-
proach they considered appropriate for each patient.
The therapists working in the out-patient units in gen-
eral mostly use psychotherapy, cognitive behavioural
therapy, and some pharmacotherapy.
Data collection/outcome measures
At baseline the participants completed a questionnaire
on background information (Table 1). Outcome data
were completed at baseline and six weeks after treat-
ment started. Main outcome measures after six weeks of
treatment were Treatment Alliance Scale (TAS) [40] and
Client Satisfaction Questionnaire (CSQ) [44].
The Treatment Alliance Scale (TAS) is a 10-item scale
measuring patients’ experience of alliance with therapists
[40], providing a total score from 0 to 6 (strongest alli-
ance). TAS was translated to Norwegian for the present
study and we replaced “treatment team” with “therapist”
Table 1 Patients: total sample, intervention, and control
Variables Total sample Intervention Control
N = 75 n = 37 n = 38
N (%) n (%) n (%)
Female 47 (62.7%) 26 (70.3%) 21 (55.3%)
Age (Mean (Median, Range)) 29.9 (25, 18–70) 30.5 (26, 18–64) 29.2 (25, 20–70)
Living alone 23 (30.7%) 9 (24.3%) 14 (36.8%)
Can confide in two or more persons 54 (72.0%) 30 (81.1%) 24 (63.2%)
Highest level of education
- Primary and lower secondary school 13 (17.3%) 9 (24.3%) 4 (10.5%)
- Upper secondary school 32 (42.7%) 12 (32.4%) 20 (52.6%)
- University 30 (40.0%) 16 (43.2%) 14 (36.8%)
Working 17 (22.7%) 11 (29.7%) 6 (15.8%)
In education 24 (32.0%) 11 (29.7%) 13 (34.2%)
Currently using medication for mental health problems 32 (42.7%) 14 (37.8%) 18 (47.4%)
Previous treatment for mental health problems 59 (78.7%) 29 (78.4%) 30 (78.9%)
Previously hospitalized for mental health problems 14 (18.7%) 8 (21.6%) 6 (15.8%)
Numbers are N/n (%) unless otherwise stated.
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solid psychometric properties [40]. The Treatment Alli-
ance Scale was chosen since it includes questions consid-
ered highly relevant; whether the patient experienced the
therapist as respectful, understanding, attentive, helpful,
and accessible. The questions also included the patients’
rating of collaboration, shared understanding, active par-
ticipation, and whether the treatment would be helpful.
The Client Satisfaction Questionnaire-8 (CSQ-8) mea-
sures patient satisfaction [44]. The questionnaire includes
eight items, providing a total score from 8 to 32 (highest
satisfaction). The CSQ-8 has good psychometric proper-
ties [44,45], and was translated to Norwegian for the
present study.
Several outcomes were added to investigate various
aspects:
Since the use of the PCOMS are supposed to improve
treatment results in mental health care, the Behaviour
and Symptom Identification Scale 32 (BASIS-32) [46]
was included. BASIS-32 is a 32 item questionnaire meas-
uring mental health symptoms and functioning and pro-
vides a total score from 0 to 4 (worst mental health
symptoms) [46]. BASIS-32 was translated to Norwegian
for the present study.
Patient activation is a central aspect of an active patient
role where patients and providers are more equal partners
[47]. Patient Activation Measure (PAM) was therefore
used to measure patient activation [47], providing a total
PAM score ranging from 0 to 100 (highest activation).
The validated Norwegian version was used [48].
Improved treatment results and patient activation
would also imply improved health-related quality of lifein patients, and Short Form-12v2 (SF-12v2) was there-
fore used to measure the patient’s self-reported health-
related quality of life [49]. SF-12v2 is a recognised and
much used health-related quality of life measurement.
The 12 item scores are calculated into two total scores:
The Mental Component Score (MCS), reflecting mental
health-related quality of life, and the Physical Compo-
nent Score (PCS), reflecting physical health-related qual-
ity of life. The total scores range from 0 to 100 (best
quality of life). We used the Norwegian version of
SF12v2 (SF-12v2™ Health Survey, 2004, Health Assess-
ment Lab, Medical Outcomes Trust and Quality Metric
Inc.).
Since all previous studies [34-36] investigating the ef-
fect of PCOMS have used the Outcome Rating Scale
(ORS) as primary outcome, we included the ORS and
the Session Rating Scale (SRS) as secondary outcome
measures [30]. The total scores for each scale range from
0 to 40 (best). The Norwegian versions were used.
To measure user participation, 14 statements about
participation and motivation, developed by the authors,
were added. The statements were based on the literature
and our own work on how patients and health personnel
define patient participation [13]. Baseline data were used
to conduct an exploratory factor analysis. Using varimax
rotation, two factors were found to have an eigenvalue
above 1.0, explaining nearly 63% of the variance. Three
statements on motivation for treatment constituted one
factor – “Patient motivation” (PM). Examples of state-
ments on motivation are “I want to make a large effort
to improve,” and “It is very important for me that my
mental health problems improve”. The remaining 11
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ticipation” (PP). Examples of statements on participation
are “I am treated with respect from my therapist and
others I have contact with during my treatment,” and
“My therapist is interested in hearing my opinion.” Each
statement was scored from 0 (strongly disagree) to 6
(strongly agree), and the total score was the mean of all
statements (0 to 6, where 6 is the strongest motivation
and most participation).
For the translations of TAS, CSQ, and BASIS-32, two
persons independently translated the questions from
English to Norwegian, and two other persons independ-
ently translated them from Norwegian to English. Lack
of accordance was discussed until consensus was
reached. The Norwegian versions were tested on volun-
teers. Effort was made to keep the Norwegian versions
similar to the originals.
Power calculation and sample size
Due to the lack of similar studies on treatment alliance,
the sample size was determined using the assumed clin-
ically significant difference in the BASIS-32 question-
naire (mental health symptoms and functioning). To
detect a clinically significant difference between the
groups’ BASIS-32 scores of 0.5 with a standard deviation
of 0.8 [50], 32 participants were needed in each group
(power 0.8, alpha 0.05). No interim analyses were
planned or conducted.
Randomisation and allocation
After completing baseline data, participants were rando-
mised to either PCOMS or treatment as usual, using the
university’s internet based computerised randomisation ser-
vice. There was no stratification or block randomisation.
Patients were subsequently allocated to a PCOMS therapist
or treatment as usual therapist by the unit manager. Thera-
pists could thus not influence which patients they treated.
Blinding
This was an open study and no blinding was performed.
Statistical methods
For all questionnaires, only those with at least 50% of the
items answered valid were scored. Missing values were
replaced with last value (baseline) carried forward, or if no
baseline values were available, missing values were
replaced with the mean value of the group the patient was
randomised to. Information on the number of consulta-
tions for three patients in the intervention group and nine
in the control group was not accessible from the clinic’s
administrative data system. These missing data were not
replaced. Analyses both with and without missing data
were conducted and the results were the same.Both intention to treat and per protocol analyses were
conducted [51]. The pre-defined criterion for per proto-
col analysis was that patients should have attended at
least three consultations during six weeks from the ini-
tial consultation. This would ensure that all patients
received a minimum of treatment. In addition, the
PCOMS group should have used the feedback scales in
at least 2/3 of all consultations to ensure that the
PCOMS group received the intervention.
Between group differences for TAS, CSQ, SRS, and PP
were analysed using two-tailed independent t-tests. Be-
tween group differences for the other outcomes were
analysed using analysis of covariance (ANCOVA) with
the baseline value as a covariate. Within group differ-
ences (from baseline to six weeks) were calculated using
two-tailed paired t-tests. A significance level of 5% (p ≤
0.05) was chosen to calculate confidence intervals (95%
CI). Analyses were done with SPSS 17.0 for Windows
(SPSS Inc., Chicago, IL).
Results
Participant flow
The flow of participants during recruitment and study is
described in Figure 1. Three hundred and ninety-five
out-patients were eligible and received an invitation let-
ter. Eighty-seven volunteered to participate and 12 with-
drew before randomisation. A total of 75 patients were
randomised; 37 were put in the PCOMS group and 38
in the treatment as usual group.
Baseline data
Patients
In the total sample 63% were female and the mean age
was 30 years (Table 1). 31% lived alone, and 72% had
two or more persons they could confide in. 79% had pre-
vious treatment experience for mental health problems,
and 43% were currently using medication for such
problems.
Age, gender, and referral diagnoses were collected con-
secutively for 40% (n = 157) of the total group of patients
who were eligible and invited to, but did not participate.
Due to data registration restrictions, we were not able to
collect data for all non-participating patients. The mean
age was 28.4 (range 18–71), and 58% were female. Diag-
noses at referral were also similar with the patients who
participated, with anxiety and depression as the main
diagnosis (data not shown).
Therapists
Eight therapists treated the patients in the PCOMS
group, while 17 treated the patients in the treatment as
usual group (Table 2). Four of the 17 therapists in the
treatment as usual group did not respond to a question-
naire about therapists’ characteristics, and these missing
Figure 1 Flow chart study.
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male, 76% were psychologists and 24% were psychiatric
nurses. The mean age was 41 years, they had 1–16 years
of experience with out-patient mental health treatment,Table 2 Therapists; total sample, intervention, and control
Variables Tot
Female 16
Age (Mean (Median, Range)) 41.4
Education
- Psychiatric nurse 5
- Psychologist 16
No of years worked in mental health care (Mean (Median, Range)) 9.9
No of years worked in out-patient unit (Mean (Median, Range)) 4.6
Heard about PCOMS prior to study (yes) 9
Attended course in PCOMS prior to study (yes) 2
Numbers are N/n (%) unless otherwise stated.
For categorical variables the groups have been compared using Pearson’s chi squar
For continuous variables the groups have been compared using two-tailed indepen
Four treatment as usual therapists did not return the questionnaire on these variaband 1–25 years of experience from mental health care in
general. 43% had heard about the PCOMS before, and
9.5% had previously attended a course in using the
PCOMS in clinical work. The number of therapistsal sample Intervention Control p-
valueN = 25 n = 8 n = 17
N (%) n (%) n (%)
(64%) 5 (62.5%) 11 (64.7%) 0.915
(38, 30–62) 39 (34.5, 31–62) 42.9 (41, 30–61) 0.402
0.920
(23.8%) 2 (25%) 3 (17.6%)
(76.2%) 6 (75%) 10 (58.8%)
(9, 1–25) 7.4 (5.5, 1–16) 11.4 (10, 1–25) 0.220
(3, 1–16) 3.4 (3, 1–8) 5.4 (4, 1–16) 0.292
(42.9%) 3 (37.5%) 6 (35.3%) 0.697
(9.5%) 1 (12.5%) 1 (7.7%) 0.716
e tests.
dent t-tests.
les.
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in the outpatient unit at the hospital who provided indi-
vidual treatment. The two groups of therapist were simi-
lar regarding gender, education, age, and work
experience. The PCOMS therapists treated a mean of
4.4 patients each (median 5, range 1–7), while the treat-
ment as usual therapists treated a mean of 2.4 patients
each (median 2, range 1–6).
Implementation of intervention
During the six weeks, the patients in the PCOMS group
had an average of 3.8 (range 1–9) consultations. The
patients in the treatment as usual group had an average
of 3.8 (range 1–10) consultations. In the PCOMS group
the scales were used in 92% of all consultations.
Comparison between the groups
The differences between the PCOMS group and treat-
ment as usual group on all outcome measures are pre-
sented in Table 3.
There were no differences between the groups on
treatment alliance (TAS) (mean difference = 0.08, 95% CI
−0.44 to 0.59, p = 0.760) and patient satisfaction (CSQ)
(mean difference = 0.24, 95% CI −1.85 to 2.32, p = 0.819)
six weeks after the treatment started.
There was a higher score on motivation for treatment
(PM) in the PCOMS group (estimated mean difference =
0.29, 95% CI 0.00 to 0.57, p = 0.05). There were no differ-
ences on the other outcomes.
Changes within the groups
The changes in means from baseline to six weeks after
starting treatment, for both the PCOMS group and
treatment as usual group, are presented in Table 3 (last
2 columns). Since it was not possible to complete the
outcomes on alliance (TAS), satisfaction (CSQ), treat-
ment sessions (SRS), and patient participation (PP) be-
fore starting treatment, no changes within groups could
be calculated for these variables. Two outcomes had im-
provement in the PCOMS group; patient activation
(PAM, mean diff = 3.22, 95% CI 0.70 to 5.74, p = 0.014)
and patient functioning (ORS, mean diff = 3.53, 95% CI
0.99 to 6.06, p = 0.008). There were no differences in the
treatment as usual group.
Per protocol analyses
Per protocol analyses were conducted only on partici-
pants who received the intervention they were rando-
mised to according to protocol. The predefined per
protocol criteria gave 26 participants in the intervention
group and 32 in the control group. Reasons for not
meeting the criteria in the PCOMS group were being
mistakenly allocated to the control group (four patients),
never starting treatment (one patient), not using scalesin at least 2/3 of the treatment sessions (two patients),
changing therapist to control after two sessions (one pa-
tient), and receiving less than three sessions (three
patients). Reasons for not meeting the criteria in the
treatment as usual group were never starting treatment
(two patients) and receiving less than three treatment
sessions (four patients). Patients meeting per protocol
criteria received an average of 4.0 treatment sessions
during six weeks.
The per protocol analyses showed no differences be-
tween the PCOMS group and the treatment as usual
group on alliance or satisfaction, six weeks after starting
treatment (Table 4), but, compared to the intention to
treat analysis, the absolute values tended to change in
favour of the PCOMS group. The effect size [52]
increased from 0.07 (intention to treat, Table 3) to 0.40
(per protocol, Table 4) for treatment alliance and from
0.06 to 0.31 for patient satisfaction.
The PCOMS group had higher scores than the treat-
ment as usual group on motivation for treatment (PM)
(estimated mean diff = 0.28, 95% CI 0.04 to 0.52, p =
0.024), and near significant higher scores on evaluation
of consultations (SRS) in the PCOMS group (mean diff =
3.15, 95% CI 0.07 to 6.37, p = 0.055).
For within group analysis, PAM and ORS improved
significantly in the PCOMS group, as in the intention to
treat analysis.
Discussion
Results
Six weeks after starting treatment, no significant effects
on treatment alliance and patient satisfaction from using
the PCOMS scales were found. Both hypotheses were
thus rejected. The PCOMS group had higher motivation
for treatment compared with the treatment as usual
group, and there were improvements within the PCOMS
group of patient activation (PAM) and patient function-
ing (ORS).
Strengths and limitations
The main strength of this study is that it is the first ran-
domised controlled trial on the effect on treatment alli-
ance and patient satisfaction of systematically using the
two PCOMS scales in treatment sessions. The study was
conducted in a natural setting. The sample of patients
participating in this study was similar in gender, age, and
referral diagnoses to a larger sample from this hospital
out-patient unit, indicating that the study sample were
representative of those referred to out-patient mental
health treatment. Although the therapists initially self-
selected to participate, 86% of all eligible therapists at
the out-patient units eventually participated in the study.
The results therefore have strong external validity. The
mean ORS score at baseline for the participants in the
Table 3 Intention to treat analyses
Outcomes Group Baseline Between groups at 6 weeks A) Within groups (6 weeks–baseline) B)
Mean (SD) Mean (SD) Diff. (95% CI) p-value Diff (95% CI) p-value
TAS INT 4.63 (1.1) 0.08 (−0.44, 0.59) 0.760
CTRL 4.55 (1.1)
CSQ INT 24.42 (5.0) 0.24 (−1.85, 2.32) 0.819
CTRL 24.18 (4.0)
BASIS-32† INT 1.05 (0.5) 1.00 (0.5) 0.02 (−0.20, 0.24) 0.882 −0.05 (−0.21, 0.12) 0.551
CTRL 1.23 (0.5) 1.08 (0.6) −0.15, (−0.33, 0.03) 0.107
PAM INT 35.36 (9.1) 38.58 (7.7) 1.58 (−2.28, 5.44) 0.417 3.22 (0.70, 5.74)* 0.014
CTRL 36.09 (9.1) 37.34 (10.8) 1.25 (−2.43, 4.94) 0.495
MCS (SF-12) INT 38.19 (8.4) 40.63 (9.2) 0.03 (−3.5, 3.6) 0.989 2.44 (−0.49, 5.38) 0.100
CTRL 38.08 (5.9) 40.55 (7.9) 2.47 (−0.21, 5.16) 0.070
PCS (SF-12) INT 48.05 (7.6) 49.10 (8.9) 0.92 (−2.05, 3.89) 0.539 1.04 (−1.06, 3.14) 0.321
CTRL 48.29 (7.9) 48.35 (8.7) 0.69 (−2.22, 2.36) 0.952
ORS INT 18.64 (8.2) 22.17 (9.2) 1.73 (−1.89, 5.35) 0.344 3.53 (0.99, 6.06)* 0.008
CTRL 16.83 (6.7) 19.33 (8.8) 2.51 (−0.41, 5.43) 0.090
SRS INT 31.88 (7.9) 1.46 (−2.28, 5.19) 0.440
CTRL 30.43 (8.3)
PM INT 5.34 (0.8) 5.59 (0.6) 0.29 (0.00, 0.57)* 0.050 0.25 (−0.06, 0.57) 0.113
CTRL 5.31 (0.8) 5.30 (0.8) −0.02 (−0.23, 0.19) 0.874
PP INT 4.43 (1.0) −0.09 (−0.52, 0.34) 0.663
CTRL 4.52 (0.9)
Comparison of outcomes between the intervention group (INT, n = 37) and control group (CTRL, n = 38) six weeks after treatment start, and within each group
from baseline to six weeks.
TAS = Treatment alliance score, CSQ = Client satisfaction questionnaire, BASIS-32 = The behavior and symptom identification scale 32, PAM = Patient activation
measure, MCS (SF-12) = Mental Component Score (Short form-12), PCS (SF-12) = Physical Component Score (Short form-12), ORS = Outcome rating scale, SRS =
Session rating scale, PM = Patient motivation, PP = Patient participation.
A) The between-group mean differences for TAS, CSQ, SRS and PP have been calculated using two-tailed independent t-tests. The between-group estimated
mean differences for BASIS-32, PAM, SF12, ORS, and PM have been calculated using analysis of covariance (ANCOVA), adjusted for baseline values.
B) The within group differences have been calculated using two-tailed paired t-test.
† Decrease in score indicates improvement (less mental health symptoms) for BASIS-32. For the other outcomes, increased score indicates improvement.
* p-value ≤0.05.
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is considered the cut-off for those in need of treatment
[30], this was a suitable sample from mental health care.
The high adherence to the use of the scales, which was
used in 92% of the consultations, confirms that the inter-
vention was delivered as planned. To fortify fidelity to the
study design, the treatment as usual therapists were re-
peatedly instructed to avoid using any feedback scales in
the consultations, but the consultations were not video or
audio taped. We found no indications that feedback scales
were used in the treatment as usual group.
The training the PCOMS therapists received was simi-
lar to previous studies [34-37], and in accordance with
training given for clinical purposes to improve patient
functioning and progress [43]. According to Miller and
colleagues [30], patients using PCOMS should have a
change of at least 5 points on the ORS score to show re-
liable change after three consultations. In the present
study, the mean change after three consultations was 6.6points, indicating that the sample followed the expected
treatment progress.
The size of the study might be a limitation. Given the
results for treatment alliance in the per protocol analysis
(difference in TAS = 0.32, standard deviation 0.8) and
that additional patients had got the same results, a total
of 113 patients in each group would be needed to get a
result with a p-value < 0.05 (power 0.8, alpha 0.05).
Cronbach’s alpha was calculated and found satisfactory
for the outcome measures that were translated to Norwe-
gian for this study. The results were 0.89 for BASIS-32
(mental health symptoms and functioning), 0.93 for TAS
(treatment alliance), and 0.96 for CSQ (patient satisfaction).
Alliance and satisfaction
We hypothesised that, six weeks after starting treatment,
treatment alliance and patient satisfaction would be
higher in the PCOMS group than the treatment as usual
group. Both hypotheses were rejected. That there were
Table 4 Per protocol analyses
Outcomes Group Baseline Between groups at 6 weeks A) Within groups (6 weeks–baseline) B)
Mean (SD) Mean (SD) Diff. (95% CI) Diff (95% CI) p-value
TAS INT 5.01 (0.8) 0.32 (−0.11, 0.75) 0.137
CTRL 4.69 (0.8)
CSQ INT 25.59 (4.0) 1.16 (−0.84, 3.16) 0.248
CTRL 24.43 (3.6)
BASIS-32† INT 1.10 (0.5) 1.03 (0.5) 0.04 (−0.22, 0.30) −0.07 (−0.27, 0.14) 0.515
CTRL 1.27 (0.6) 1.09 (0.6) 0.766 −0.18 (−0.37, 0.01) 0.069
PAM INT 35.17 (6.4) 39.43 (7.0) 2.53 (−2.04, 7.10) 0.272 4.26 (1.71, 6.81)* 0.002
CTRL 36.17 (8.8) 37.29 (10.5) 1.12 (−3.15, 5.40) 0.596
MCS (SF-12) INT 37.41 (7.5) 39.94 (7.8) −0.29 (−4.21, 3.63) 0.883 2.54 (−0.40, 5.48) 0.088
CTRL 37.37 (6.1) 40.21 (8.5) 2.84 (−0.23, 5.92) 0.069
PCS (SF-12) INT 47.46 (8.4) 48.84 (9.9) 1.42 (−2.20, 5.04) 0.434 1.38 (−1.48, 4.24) 0.330
CTRL 48.09 (8.6) 47.90 (9.0) −0.18 (−2.70, 2.34) 0.883
ORS INT 17.55 (7.0) 22.07 (9.0) 2.68 (−1.74, 7.09) 0.229 4.52 (1.31, 7.73)* 0.008
CTRL 16.16 (7.0) 18.63 (9.2) 2.47 (−0.94, 5.89) 0.150
SRS INT 34.68 (5.6) 3.15 (0.07, 6.37) 0.055
CTRL 31.53 (6.4)
PM INT 5.38 (0.8) 5.65 (0.5) 0.28 (0.04, 0.42) 0.024 0.27 (−0.04, 0.57) 0.081
CTRL 5.32 (0.9) 5.34 (0.7) 0.02 (−0.14, 0.19) 0.788
PP INT 4.73 (0.7) 0.07 (−0.29, 0.42) 0.706
CTRL 4.66 (0.6)
Comparison of outcomes between the intervention group (INT, n = 26) and control group (CTRL, n = 32) six weeks after treatment start, and within each group
from baseline to six weeks.
TAS = Treatment alliance score, CSQ = Client satisfaction questionnaire, BASIS-32 = The behavior and symptom identification scale 32, PAM = Patient activation
measure, MCS (SF-12) = Mental Component Score (Short form-12), PCS (SF-12) = Physical Component Score (Short form-12), ORS = Outcome rating scale, SRS =
Session rating scale, PM = Patient motivation, PP = Patient participation.
A) The between-group mean differences for TAS, CSQ, SRS and PP have been calculated using two-tailed independent t-tests. The between-group estimated
mean differences for BASIS-32, PAM, SF12, ORS, and PM have been calculated using analysis of covariance (ANCOVA), adjusted for baseline values.
B) The within group differences have been calculated using two-tailed paired t-test.
† Decrease in score indicates improvement (less mental health symptoms) for BASIS-32. For the other outcomes, increased score indicates improvement.
* p-value ≤0.05.
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questions if the alleged increase in alliance when using
the PCOMS scales is due to treatment in general or
feedback techniques embedded in treatment, and not
the use of the scales. The observation that the differ-
ences between the groups in the per protocol analysis
(where only those who used the scales as intended were
included) was more in favour of the PCOMS group than
in the intention to treat analysis, warrants a larger study
to draw a more firm conclusion.
The instrument used to measure treatment alliance in
this study (Treatment Alliance Scale (TAS)) has been rela-
tively little used and tested so far, but was chosen since it
is a validated questionnaire which is easy to complete.
More used instruments like The Revised Helping Alliance
Questionnaire [53] and The Working Alliance Inventory
[54] could have been chosen. However, a meta-analysis on
alliance questionnaires reported no difference in ability to
measure alliance across instruments [24].Since the Session Rating Scale (SRS) is the patient’s
rating of the relation with the therapist and the degree
of agreement on goals, methods, and treatment ap-
proach, it has similarities to a treatment alliance rating.
In the present study, the per protocol analysis showed
that the PCOMS group had a higher score on SRS that
was near to a p-value of 0.05. This could indicate that
the feedback scales have an effect on an alliance-related
dimension, which is encompassed by the SRS but not
the TAS. The results on the SRS have to be interpreted
with caution since the PCOMS group was exposed to
the scales in the treatment sessions, and this might have
influenced their answers.
Since the most important factor affecting patient satis-
faction is the relationship between patient and profes-
sional [16], it is reasonable that the results on treatment
alliance and patient satisfaction in the present study
were consistent. The lack of effect on patient satisfaction
is in line with previous investigations where clinicians
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quality of life [17,18].
Motivation
The present study found that the PCOMS group had
higher motivation for treatment than the treatment as
usual group, six weeks after starting treatment. Patients’
expectations of treatment effect have been shown by
some to be important predictors of treatment outcome
[55], while others have shown that motivation does not
predict treatment result [56]. It has been argued that
motivation is an internal patient factor which cannot be
influenced, while others highlight social factors as im-
portant for changing motivation [57]. Research has
shown that motivation correlates with alliance at treat-
ment start [58]. In the literature, motivation has been
linked to setting and revising goals, encouraging the
patient’s view, and welcoming the patient’s value system
[57]. These factors are central when using patient feed-
back scales.
Treatment outcome
Previous randomised controlled trials have shown that
use of PCOMS was superior to treatment as usual after
between 5 and 8 sessions [34-36]. These studies have
used the ORS scale as the main outcome measure. How-
ever, in the present study there were no short-term dif-
ferences between the PCOMS group and the treatment
as usual group regarding the ORS scores. This could be
due to the shorter follow up time in this study. Never-
theless, the mean ORS score for the PCOMS group fol-
lowed the predicted score during the consultations,
indicating that this group had good progress during
treatment [30]. Furthermore, there was a clear change in
the ORS scores from baseline to six week follow-up
within the PCOMS group (mean difference = 3.53, 95%
CI 0.99 to 6.06, p = 0.008), and not within the treatment
as usual group (mean difference = 2.51, -0.41 to 5.43, p =
0.090). A longer follow up time is needed to make more
exact comparisons with other studies investigating the ef-
fect of use of PCOMS.
Conclusion
The present study is the first randomised controlled trial
investigating the short-term effect on treatment alliance
and patient satisfaction of using the PCOMS scales in
out-patient treatment. Compared to treatment as usual,
there were no effects on alliance and satisfaction from
using the scales six weeks after starting treatment. The
PCOMS group had higher motivation for treatment. In
addition, the per protocol analyses showed higher effect
sizes. Future investigations in a larger study are therefore
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